Anyone who's sat through a batch record review knows the drill — page after page of handwritten entries, stamps, corrections, and signatures, all needing a human eye before a product can move forward. OCR was supposed to speed this up, but honestly, it only gets you halfway there. It reads text. It doesn't understand what that text means, whether a value is out of range, or if a signature is missing where one's required. That's the real gap AI-powered document intelligence is closing. Instead of just digitizing a batch record in pharma operations, modern systems can actually interpret it — spotting deviations, cross-checking data against SOPs, and flagging compliance risks before they become bigger problems. For teams tired of manual bottlenecks, this isn't just a nice upgrade. It's becoming the baseline expectation for how batch records get reviewed going forward.
Topics
